KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Invested Capital (2016 - 2025)

Pacific Biosciences Of California has reported Invested Capital over the past 16 years, most recently at $5.3 million for Q4 2025.

  • Quarterly results put Invested Capital at $5.3 million for Q4 2025, down 98.94% from a year ago — trailing twelve months through Dec 2025 was $5.3 million (down 98.94% YoY), and the annual figure for FY2025 was $5.3 million, down 98.94%.
  • Invested Capital for Q4 2025 was $5.3 million at Pacific Biosciences Of California, down from $36.1 million in the prior quarter.
  • Over the last five years, Invested Capital for PACB hit a ceiling of $1.1 billion in Q2 2023 and a floor of $5.3 million in Q4 2025.
  • Median Invested Capital over the past 5 years was $626.6 million (2022), compared with a mean of $523.4 million.
  • Biggest five-year swings in Invested Capital: skyrocketed 523.9% in 2021 and later plummeted 98.94% in 2025.
  • Pacific Biosciences Of California's Invested Capital stood at $792.6 million in 2021, then dropped by 7.27% to $735.0 million in 2022, then fell by 4.58% to $701.3 million in 2023, then dropped by 27.76% to $506.6 million in 2024, then plummeted by 98.94% to $5.3 million in 2025.
  • The last three reported values for Invested Capital were $5.3 million (Q4 2025), $36.1 million (Q3 2025), and $61.5 million (Q2 2025) per Business Quant data.